dna vaccination with plasmids encoding single chain of mhci/peptide/β2 m complexes elicits robust...

1
12 Abstracts / Molecular Immunology 51 (2012) 5–41 DNA vaccination with plasmids encoding single chain of MHCI/peptide/2 m complexes elicits robust CD8 T cell immu- nity and pathogen protection Sojung Kim, Lijin Li, Javier Carrero, Michael Diamond, William Gillanders, Ted Hansen, Janet Connolly Washington University, St. Louis Vaccination with plasmid DNA encoding single chain trimers (SCT) of MHC class I, in which heavy chain, peptide and 2 m are covalently attached with flexible linkers, has been shown by our lab and others to elicit robust CD8 T cell responses to pathogens and tumors. Indeed, we found that SCT vaccines could protect in mouse models of Listeria or WNV infection. To maximize SCT vaccine effi- cacy, it was important to determine if there is a requirement for CD4 T cell help and to understand the mechanism by which anti- gen is presented. SCT constructs were generated that included a CD4 helper T cell epitope and were used as DNA vaccines. Nei- ther primary nor memory CD8 T cell responses were dependent upon CD4 T cell help; however the memory CD8 T cell response was enhanced by either antigen-specific or non-cognate CD4 T cell help. We speculate that this relative lack of helper dependency is the result of a high level of stable Ag presentation by the SCT after DNA vaccination. Direct presentation and cross-presentation have been implicated in antigen presentation following DNA vac- cination but the relative contribution of each of these pathways remains controversial. Highly relevant to the question, we show that SCT are recognized as intact structures following DNA vacci- nation. OVAp5Y (SIINYEKL) is an altered peptide ligand of SIINFEKL that can be recognized by T cells in the context of the SCT, but cannot be directly or cross-presented by native Kb. Importantly, OVAp5Y DNA did not induce a response whereas DNA vaccines incorporat- ing Kb/OVA and KbOVAp5Y stimulated CD8 T cell responses. Thus direct presentation of the SCT in the absence of cross-presentation was sufficient to elicit a robust CD8 T cell response after DNA vacci- nation. Furthermore an SCT incorporating an 3 mutant that cannot be recognized by CD8 induced a negligible response compared to wild type. Similarly a chimeric HLA-A2/Db 3 SCT encoding a WNV epitope induces a much stronger CD8 T cell response than native HLA-A2 WNV SCTs following DNA immunization in HHDII mice. Thus, based on several experimental findings, SCTs are primarily recognized as intact structures after DNA vaccination. This recog- nition could result from direct incorporation of the SCT by APC or by membrane transfer through a mechanism known as cross-dressing or trogocytosis. In any case, the presentation of Ag by an intact SCT in a relatively helper independent manner likely explains its efficacy as a DNA vaccine. doi:10.1016/j.molimm.2012.02.027 Structural and mechanistic aspects of the peptide loading com- plex Peter Cresswell Howard Hughes Medical Institute, Yale University School of Medicine High affinity peptide binding to MHC class I molecules is facil- itated by the peptide loading complex (PLC). The PLC resides in the endoplasmic reticulum (ER) and contains the TAP transporter, a disulfide-linked heterodimer of tapasin and the thiol oxidore- ductase ERp57, calreticulin and an MHC class I-2 m heterodimer. TAP transports peptides into the ER and the concerted actions of tapasin/ERp57, calreticulin and the enzyme UDP-glucose glycopro- tein transferase (UGT-1), which maintains the single class I glycan of peptide-free human HLA class I molecules in a monoglucosylated form, facilitate the binding of high affinity peptides to the MHC class I molecule. We are re-addressing the issue of the stoichiometry of the PLC using a single molecule approach and are attempting to unravel how association and dissociation of MHC class I molecules from the PLC is regulated. These issues will be discussed. doi:10.1016/j.molimm.2012.02.028 Unexpectedly high prevalence of TAP-independent MHC class I epitopes from vaccinia virus and their contribution to protec- tion in vivo Margarita Del Val , Silvia Lázaro, Salvador Iborra, Manuel Ramos, Daniel López CD8+ T lymphocytes screen peptides displayed at the plasma membrane by major histocompatibility complex (MHC) class I molecules. It is accepted that most of these peptides result from cytosolic proteolysis. TAP transporters associated with antigen pre- sentation are crucial to deliver these peptides into the endoplasmic reticulum, where they meet nascent MHC class I molecules. Indi- vidual TAP-independent antigen processing pathways have been described, but the extent to which they globally contribute to CD8+ T-cell responses is still unclear. In this report, we study vaccinia virus (VACV), a virus successfully used to eradicate smallpox and currently considered as a vaccine vector. About 13% of the primary CD8+ T-lymphocyte response of infected mice was directed against viral epitopes presented by MHC class I molecules independently of TAP in infected dendritic cells. Analysis of 30 individual VACV epitopes revealed that as many as 12 epitopes were presented inde- pendently of TAP. Interestingly, the primary immunodominance hierarchy was radically different in TAP1-deficient and in wild type animals. CD8+ T-lymphocyte lines mono-specific for most of these epitopes were established from TAP1-deficient animals. Half of these TAP-independent peptides derived from membrane viral proteins. The remaining 6 derived from cytosolic viral proteins, and yet all gained access to vesicular or secretory antigen presentation pathways in the absence of TAP. Notably, TAP-independent epi- topes were more frequently derived from viral structural proteins expressed at the late phase of VACV infection. Finally, CD8+ T lym- phocytes primed by two of these peptides were equally efficient in providing protection against viral infection in TAP-deficient and in wild type mice. These findings underline the remarkable contri- bution of TAP-independent antigen processing pathways to CD8+ T-cell priming and to protection from infection with VACV. doi:10.1016/j.molimm.2012.02.029 Antigen targeting to splenic CD169+ macrophages induces strong humoral immune responses and CD4+ T cell activation Henrike Veninga, Ellen Borg, Hakan Kalay, Yvette van Kooyk, Georg Kraal, Joke M.M. den Haan VU University Medical Center, Amsterdam Immune responses against blood-borne pathogens are raised in the spleen. The blood enters the spleen in the marginal zone and here resident macrophages are strategically located to capture antigens. We have recently shown a previously unappreciated role for marginal metallophilic CD169+ macrophages in the induction of cytotoxic T cell responses. To investigate the role of CD169+ macrophages in the induction of humoral immune responses, we conjugated ovalbumin (OVA) to antibodies specific for CD169 and DEC205 and compared antigen targeting to CD169+ macrophages to targeting to DEC205+ den- dritic cells (DC). Both targeting strategies induced robust anti-OVA antibody responses at early time points after immunization. How-

Upload: sojung-kim

Post on 10-Sep-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

1 mmun

DMn

SG

(catmcCgCtuwhiahcrtntbDidwnbweHTrnmoSe

d

Sp

P

itadTttof

2 Abstracts / Molecular I

NA vaccination with plasmids encoding single chain ofHCI/peptide/�2 m complexes elicits robust CD8 T cell immu-

ity and pathogen protection

ojung Kim, Lijin Li, Javier Carrero, Michael Diamond, Williamillanders, Ted Hansen, Janet Connolly ∗

Washington University, St. Louis

Vaccination with plasmid DNA encoding single chain trimersSCT) of MHC class I, in which heavy chain, peptide and �2 m areovalently attached with flexible linkers, has been shown by our labnd others to elicit robust CD8 T cell responses to pathogens andumors. Indeed, we found that SCT vaccines could protect in mouse

odels of Listeria or WNV infection. To maximize SCT vaccine effi-acy, it was important to determine if there is a requirement forD4 T cell help and to understand the mechanism by which anti-en is presented. SCT constructs were generated that included aD4 helper T cell epitope and were used as DNA vaccines. Nei-her primary nor memory CD8 T cell responses were dependentpon CD4 T cell help; however the memory CD8 T cell responseas enhanced by either antigen-specific or non-cognate CD4 T cellelp. We speculate that this relative lack of helper dependency

s the result of a high level of stable Ag presentation by the SCTfter DNA vaccination. Direct presentation and cross-presentationave been implicated in antigen presentation following DNA vac-ination but the relative contribution of each of these pathwaysemains controversial. Highly relevant to the question, we showhat SCT are recognized as intact structures following DNA vacci-ation. OVAp5Y (SIINYEKL) is an altered peptide ligand of SIINFEKLhat can be recognized by T cells in the context of the SCT, but cannote directly or cross-presented by native Kb. Importantly, OVAp5YNA did not induce a response whereas DNA vaccines incorporat-

ng Kb/OVA and KbOVAp5Y stimulated CD8 T cell responses. Thusirect presentation of the SCT in the absence of cross-presentationas sufficient to elicit a robust CD8 T cell response after DNA vacci-ation. Furthermore an SCT incorporating an �3 mutant that cannote recognized by CD8 induced a negligible response compared toild type. Similarly a chimeric HLA-A2/Db �3 SCT encoding a WNV

pitope induces a much stronger CD8 T cell response than nativeLA-A2 WNV SCTs following DNA immunization in HHDII mice.hus, based on several experimental findings, SCTs are primarilyecognized as intact structures after DNA vaccination. This recog-ition could result from direct incorporation of the SCT by APC or byembrane transfer through a mechanism known as cross-dressing

r trogocytosis. In any case, the presentation of Ag by an intactCT in a relatively helper independent manner likely explains itsfficacy as a DNA vaccine.

oi:10.1016/j.molimm.2012.02.027

tructural and mechanistic aspects of the peptide loading com-lex

eter Cresswell

Howard Hughes Medical Institute, Yale University School of Medicine

High affinity peptide binding to MHC class I molecules is facil-tated by the peptide loading complex (PLC). The PLC resides inhe endoplasmic reticulum (ER) and contains the TAP transporter,

disulfide-linked heterodimer of tapasin and the thiol oxidore-uctase ERp57, calreticulin and an MHC class I-�2 m heterodimer.AP transports peptides into the ER and the concerted actions of

apasin/ERp57, calreticulin and the enzyme UDP-glucose glycopro-ein transferase (UGT-1), which maintains the single class I glycanf peptide-free human HLA class I molecules in a monoglucosylatedorm, facilitate the binding of high affinity peptides to the MHC class

ology 51 (2012) 5–41

I molecule. We are re-addressing the issue of the stoichiometry ofthe PLC using a single molecule approach and are attempting tounravel how association and dissociation of MHC class I moleculesfrom the PLC is regulated. These issues will be discussed.

doi:10.1016/j.molimm.2012.02.028

Unexpectedly high prevalence of TAP-independent MHC class Iepitopes from vaccinia virus and their contribution to protec-tion in vivo

Margarita Del Val ∗, Silvia Lázaro, Salvador Iborra, Manuel Ramos,Daniel López

CD8+ T lymphocytes screen peptides displayed at the plasmamembrane by major histocompatibility complex (MHC) class Imolecules. It is accepted that most of these peptides result fromcytosolic proteolysis. TAP transporters associated with antigen pre-sentation are crucial to deliver these peptides into the endoplasmicreticulum, where they meet nascent MHC class I molecules. Indi-vidual TAP-independent antigen processing pathways have beendescribed, but the extent to which they globally contribute to CD8+T-cell responses is still unclear. In this report, we study vacciniavirus (VACV), a virus successfully used to eradicate smallpox andcurrently considered as a vaccine vector. About 13% of the primaryCD8+ T-lymphocyte response of infected mice was directed againstviral epitopes presented by MHC class I molecules independentlyof TAP in infected dendritic cells. Analysis of 30 individual VACVepitopes revealed that as many as 12 epitopes were presented inde-pendently of TAP. Interestingly, the primary immunodominancehierarchy was radically different in TAP1-deficient and in wildtype animals. CD8+ T-lymphocyte lines mono-specific for most ofthese epitopes were established from TAP1-deficient animals. Halfof these TAP-independent peptides derived from membrane viralproteins. The remaining 6 derived from cytosolic viral proteins, andyet all gained access to vesicular or secretory antigen presentationpathways in the absence of TAP. Notably, TAP-independent epi-topes were more frequently derived from viral structural proteinsexpressed at the late phase of VACV infection. Finally, CD8+ T lym-phocytes primed by two of these peptides were equally efficientin providing protection against viral infection in TAP-deficient andin wild type mice. These findings underline the remarkable contri-bution of TAP-independent antigen processing pathways to CD8+T-cell priming and to protection from infection with VACV.

doi:10.1016/j.molimm.2012.02.029

Antigen targeting to splenic CD169+ macrophages inducesstrong humoral immune responses and CD4+ T cell activation

Henrike Veninga, Ellen Borg, Hakan Kalay, Yvette van Kooyk,Georg Kraal, Joke M.M. den Haan ∗

VU University Medical Center, Amsterdam

Immune responses against blood-borne pathogens are raisedin the spleen. The blood enters the spleen in the marginal zoneand here resident macrophages are strategically located to captureantigens. We have recently shown a previously unappreciated rolefor marginal metallophilic CD169+ macrophages in the inductionof cytotoxic T cell responses.

To investigate the role of CD169+ macrophages in the inductionof humoral immune responses, we conjugated ovalbumin (OVA) to

antibodies specific for CD169 and DEC205 and compared antigentargeting to CD169+ macrophages to targeting to DEC205+ den-dritic cells (DC). Both targeting strategies induced robust anti-OVAantibody responses at early time points after immunization. How-